Loading organizations...
§ Private Profile · Palo Alto, CA, USA
Clinical-stage biopharmaceutical company developing precision oncology therapies for cancer patients, focused on RAS and PI3K-driven tumors.
BridgeBio Oncology Therapeutics (BBOT) is a clinical stage biopharmaceutical company based in South San Francisco, California, that develops novel small molecule inhibitors for precision oncology. The enterprise targets well validated genetic drivers of tumors, specifically focusing on treating patients with complex RAS and PI3K pathway malignancies. Operating with a workforce of 92 employees, the firm advances a pipeline of targeted cancer therapies that includes its lead KRASG12C inhibitor candidate. BBOT secured $200 million in private financing in May 2024 from a syndicate of institutional investors including Cormorant Asset Management, Omega Funds, Deerfield, and GV. The company subsequently completed a special purpose acquisition company merger to list its shares publicly on the Nasdaq exchange in February 2025. The organization was originally established in 2016 as an internal BridgeBio Pharma program before spinning out under Chief Executive Officer Eli Wallace.
BBOT has raised $22.0M across 3 funding rounds.
BBOT has raised $22.0M in total across 3 funding rounds.
Bbot is a technology company that builds a contactless ordering and payment platform for the hospitality industry, enabling restaurants, bars, hotels, food halls, and similar venues to manage digital menus, in-store and online orders, payments, and analytics from a centralized dashboard.[1][2][3][5] It serves hospitality businesses by solving operational inefficiencies like long wait times, staff shortages, and fragmented ordering systems, allowing faster table turnovers, higher sales, and seamless integrations with POS systems, loyalty programs, and third-party tools like Toast or Oracle Hospitality.[2][5][6] Prior to its acquisition by DoorDash in March 2022, Bbot raised $22.12M in funding and demonstrated strong growth in streamlining hospitality operations.[1][2]
Bbot was founded in 2017 by former Navy officers and nuclear engineers who met while working on mission-critical instrumentation and control systems for submarines and aircraft carriers.[3] After leaving the Navy, they reunited to initially develop a robotic drink delivery system for restaurants, which evolved into a comprehensive software platform for digital menus, contactless ordering, and payments.[3] Early traction came from its reliability—drawing on the founders' experience with high-stakes systems—positioning it as foundational infrastructure akin to Stripe or Twilio for food tech, enabling integrations and scalability for small businesses.[3] This growth led to its acquisition by DoorDash in March 2022, expanding DoorDash's tools for restaurant partners.[1][3][5]
Bbot rode the post-pandemic surge in contactless tech and digital transformation for hospitality, addressing labor shortages and demand for frictionless in-store experiences amid rising online ordering.[1][5] Its timing aligned with market forces like DoorDash's expansion into merchant tools, making it a key enabler for restaurants competing with delivery giants through integrated first-party solutions.[3][5] By providing robust infrastructure, Bbot influenced the ecosystem like foundational platforms in fintech, unlocking innovation for food tech startups and empowering small venues to scale digitally.[3]
Post-acquisition, Bbot's platform continues evolving within DoorDash, likely enhancing enterprise tools for hospitality amid ongoing trends like AI-driven personalization and hybrid dine-in/delivery models. Its founders' pivot to Allen Control Systems signals a shift to defense tech, but Bbot's legacy as reliable ordering infrastructure positions DoorDash to capture more in-store revenue share. As hospitality rebounds, expect deeper AI integrations and global expansion, solidifying its role in making operations "a whole lot easier" for venues worldwide.[3][5]
BBOT has raised $22.0M across 3 funding rounds. Most recently, it raised $15.0M Series A in July 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 1, 2021 | $15M Series A | CRV | Blue Note Ventures, Insight Partners, Offline Ventures, RSE Ventures, John Ives, Thomas Noonan | Announced |
| Jan 1, 2021 | $4M Seed | Rally Ventures | Andreessen Horowitz, Craft Ventures, CRV, Seven Seven SIX, The HIT Forge, Andre Iguodala, Brandon Leonardo, Gautam Gupta, Katy Perry, Manish Chandra, MAX Mullen, Odell Beckham JR., Stacy Brown Philpot, Varsha RAO | Announced |
| Jul 1, 2020 | $3M Seed | Craft Ventures | Acequia Capital, Album VC, Andreessen Horowitz, CRV, Hanaco Ventures, Seven Seven SIX, Startup Ignition Ventures, The HIT Forge, Andre Iguodala, Brandon Leonardo, Gautam Gupta, Justin Timberlake, Katy Perry, Manish Chandra, MAX Mullen, Odell Beckham JR., Stacy Brown Philpot, Varsha RAO | Announced |
BBOT has raised $22.0M in total across 3 funding rounds.
BBOT's investors include CRV, Blue Note Ventures, Insight Partners, Offline Ventures, RSE Ventures, John Ives, Thomas Noonan, Rally Ventures, Andreessen Horowitz, Craft Ventures, Seven Seven Six, The Hit Forge.